Development and optimization of etrasimod-loaded pH-dependent nanoparticles for colon targeted drug delivery

Rahul Godge; Tejas Sahane; Shubham  Mhaske; Sneha  Vikhe; Santosh  Dighe

doi:10.69857/joapr.v13i6.1625

Authors

Rahul Godge Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, India, 413736
Tejas Sahane Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, India, 413736
Shubham Mhaske Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, India, 413736
Sneha Vikhe Department of Pharmaceutical Quality Assurance, Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, India, 413736
Santosh Dighe Department of Pharmacology, Pravara Rural College of Pharmacy, Pravaranagar, Loni (Bk), Ahmednagar, Maharashtra, India, 413736

DOI:

https://doi.org/10.69857/joapr.v13i6.1625

Keywords:

Etrasimod, pH-dependent nanoparticles, Colon-targeted delivery, Factorial design, Inflammatory bowel disease, Controlled release

Abstract

Background: Etrasimod-loaded pH-sensitive nanoparticles offer a promising strategy for targeted drug delivery to the colon, minimizing systemic exposure and enhancing therapeutic efficacy. A Quality-by-Design framework enables systematic optimization of formulation parameters to ensure robust performance and site-specific release. This represents the first systematic development of pH-responsive nanoparticles for etrasimod delivery and the first application of factorial design optimization for S1P receptor modulator nanoformulations. Methodology: Etrasimod-loaded pH-dependent nanoparticles were prepared via nanoprecipitation using Eudragit S100 and Eudragit RL100 polymers. The formulation was optimised using a 3² full factorial design with polymer concentrations as independent variables. The nanoparticles were characterised by particle size, zeta potential, entrapment efficiency, and drug release. The optimised formulation underwent comprehensive physicochemical characterisation (FTIR, DSC) and 6-month accelerated stability testing. Results and Discussion: The optimised formulation (TF5) containing 90% Eudragit S100 and 10% Eudragit RL100 exhibited optimal characteristics with a particle size of 142.6±5.4 nm, zeta potential of -23.5±1.8 mV, and entrapment efficiency of 73.4±3.2%. FTIR and DSC studies confirmed drug-polymer compatibility with minimal interaction. The in vitro release profile demonstrated controlled initial release (9.8% at 1 hour) followed by complete drug liberation (94.2% at 12 hrs) at pH 7.2. The formulation remained stable for 6 months at 40 °C ± 2 °C and 75% ± 5% RH, with minimal changes in critical quality attributes. Conclusion: The developed pH-dependent nanoparticulate system offers a promising platform for colon-targeted delivery of etrasimod, demonstrating optimal physicochemical properties, controlled release characteristics, and excellent stability. This formulation approach shows potential to improve therapeutic outcomes in inflammatory bowel disease by enhancing colonic drug delivery.

Downloads

Download data is not yet available.

References

Stallmach A, Atreya R, Grunert PC. Treatment strategies in inflammatory bowel diseases. Dtsch. Ärztebl. Int., 120(45), 768 (2023) https://doi.org/10.3238/arztebl.m2023.0142

Chen L, Xu Y. Dissecting the rising tide of inflammatory bowel disease among youth in a changing world: insights from GBD 2021. Int. J. Colorectal Dis., 40(1), 44 (2025) https://doi.org/10.1007/s00384-025-04821-0

Burisch J, Zhao M. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol. Hepatol., 8(5), 458–92 (2023) https://doi.org/10.1016/S2468-1253(23)00003-1

Zheng B, Wang L, Yi Y. Design strategies, advances, and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease. Asian J. Pharm. Sci., 19(4), 100943 (2024) https://doi.org/10.1016/j.ajps.2024.100943

Deljavan Ghodrati A, Comoglu T. An overview on recent approaches for colonic drug delivery systems. Pharm. Dev. Technol., 29(6), 566–81 (2024) https://doi.org/10.1080/10837450.2024.2362353

Marsal J, Barreiro-de Acosta M, Blumenstein I. Management of non-response and loss of response to anti-tumor necrosis factor therapy in inflammatory bowel disease. Front. Med., 9, 897936 (2022) https://doi.org/10.3389/fmed.2022.897936

Pellegrino R, Imperio G. Small molecules in the treatment of acute severe ulcerative colitis: a review of current evidence. Pharmaceuticals, 18(3), 308 (2025) https://doi.org/10.3390/ph18030308

Yan X, Xie S. Targets for the immune balance of biologics in inflammatory bowel disease. Nature Cell and Science, 2(2), 85–94 (2024) https://doi.org/10.61474/ncs.2023.00025

Binish F, Xiao J. Deciphering the role of sphingosine 1-phosphate in central nervous system myelination and repair. J. Neurochem., 169(1), e16228 (2025) https://doi.org/10.1111/jnc.16228

Bertin L, Crepaldi M, Zanconato M, Lorenzon G. Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn’s disease management. Ther. Adv. Gastroenterol., 17, 17562848241303651 (2024) https://doi.org/10.1177/17562848241303651

De Anda-Flores Y, Carvajal-Millan E. Polysaccharide-based nanoparticles for colon-targeted drug delivery systems. Polysaccharides, 2(3), 626–47 (2021) https://doi.org/10.3390/polysaccharides2030038

Alshammari ND, Elkanayati R, Vemula SK. Advancements in colon-targeted drug delivery: a comprehensive review on recent techniques with emphasis on hot-melt extrusion and 3D printing technologies. AAPS PharmSciTech., 25(7), 236 (2024) https://doi.org/10.1208/s12249-024-02965-w

Singh J, Nayak P. pH-responsive polymers for drug delivery: trends and opportunities. J. Polym. Sci., 61(22), 2828–50 (2023) https://doi.org/10.1002/pol.20230403

Kulkarni N, Jain P. Advances in the colon-targeted chitosan based multiunit drug delivery systems for the treatment of inflammatory bowel disease. Carbohydr. Polym., 288, 119351 (2022) https://doi.org/10.1016/j.carbpol.2022.119351

Patil DJ, Jahagirdar SN, Mandhare SB. Validated stability indicating RP-HPLC method for the quantification of process related impurities of solifenacin and mirabegron in pharmaceutical formulations. Int. J. Drug Deliv. Technol., 14(1), 55–60 (2024) https://doi.org/10.25258/ijddt.14.1.10

Patil MA, Dhamak KV. Simultaneous estimation of montelukast and doxofylline in bulk drug and tablet dosage form by UHPLC method. Int. J. Pharm. Qual. Assur., 15(1), 106–9 (2024) https://doi.org/10.25258/ijpqa.15.1.16

Akram Z, Aati S, Ngo H. pH-dependent delivery of chlorhexidine from PGA grafted mesoporous silica nanoparticles at resin-dentin interface. J. Nanobiotechnology, 19(1), 43 (2021) https://doi.org/10.1186/s12951-021-00788-6

Tumkur PP, Gunasekaran NK, Lamani BR. Cerium oxide nanoparticles: synthesis and characterization for biosafe applications. Nanomanufacturing, 1(3), 176–89 (2021) https://doi.org/10.3390/nanomanufacturing1030013

Rahimzadeh CY, Barzinjy AA. Green synthesis of SiO2 nanoparticles from Rhus coriaria L. extract: comparison with chemically synthesized SiO2 nanoparticles. PLoS One, 17(8), e0268184 (2022) https://doi.org/10.1371/journal.pone.0268184

Rezazadeh M, Safaran R. Preparation and characterization of Eudragit L 100-55/chitosan enteric nanoparticles containing omeprazole using general factorial design: in vitro/in vivo study. Res. Pharm. Sci., 16(4), 358–69 (2021) https://doi.org/10.4103/1735-5362.319574

Alhamhoom Y, Ravi G, Osmani RA. Formulation, characterization, and evaluation of Eudragit-coated saxagliptin nanoparticles using 3 factorial design modules. Molecules, 27(21), 7510 (2022) https://doi.org/10.3390/molecules27217510

Meewan J, Somani S, Almowalad J, Laskar P. Preparation of zein-based nanoparticles: nanoprecipitation versus microfluidic-assisted manufacture, effects of PEGylation on nanoparticle characteristics and cellular uptake by melanoma cells. Int. J. Nanomedicine, 17, 2809–22 (2022) https://doi.org/10.2147/IJN.S366138

Real DA, Gagliano A. Design and optimization of pH-sensitive Eudragit nanoparticles for improved oral delivery of triclabendazole. Int. J. Pharm., 617, 121594 (2022) https://doi.org/10.1016/j.ijpharm.2022.121594

Shah AH, Rather MA. Effect of calcination temperature on the crystallite size, particle size and zeta potential of TiO2 nanoparticles synthesized via polyol-mediated method. Mater. Today Proc., 44(1), 482–8 (2021) https://doi.org/10.1016/j.matpr.2020.10.199

Turanlı Y, Acartürk F. Preparation and characterization of colon-targeted pH/time-dependent nanoparticles using anionic and cationic polymethacrylate polymers. Eur. J. Pharm. Sci., 171, 106122 (2022) https://doi.org/10.1016/j.ejps.2022.106122

Herdiana Y, Wathoni N, Shamsuddin S. Drug release study of the chitosan-based nanoparticles. Heliyon, 8(1), e08674 (2022) https://doi.org/10.1016/j.heliyon.2021.e08674

Chandrakala V, Aruna V. Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems. Emergent Mater., 5(6), 1593–615 (2022) https://doi.org/10.1007/s42247-021-00335-x

Daulay A, Gea S. Synthesis Si nanoparticles from rice husk as material active electrode on secondary cell battery with X-ray diffraction analysis. South Afr. J. Chem. Eng., 42, 32–41 (2022) https://doi.org/10.1016/j.sajce.2022.07.004

Naveed M, Batool H, Rehman SU. Characterization and evaluation of the antioxidant, antidiabetic, anti-inflammatory, and cytotoxic activities of silver nanoparticles synthesized using Brachychiton populneus leaf extract. Processes, 10(8), 1521 (2022) https://doi.org/10.3390/pr10081521

Larson NR, Hu G. pH-dependent phase behavior and stability of cationic lipid–mRNA nanoparticles. J. Pharm. Sci., 111(3), 690–8 (2022) https://doi.org/10.1016/j.xphs.2021.11.004

Sabarudin A, Fiddaroini S. Nanoparticle-enhanced 3D-connector microfluidic paper-based analytical device (3D-µPADs) for sensitive and cost-effective detection of albumin-creatinine ratio in urine sample. Sci. Technol. Indones., 10(2), 504–18 (2025) https://doi.org/10.26554/sti.2025.10.2.504-518

Santos WM, Nóbrega FP, Andrade JC. Pharmaceutical compatibility of dexamethasone with excipients commonly used in solid oral dosage forms. J. Therm. Anal. Calorim., 145(2), 361–78 (2021) https://doi.org/10.1007/s10973-020-09753-1

Özbaş F, Tüzün E. Sonosynthesis and characterization of konjac gum/xanthan gum supported iron oxide nanoparticles. Int. J. Biol. Macromol., 183, 1047–57 (2021) https://doi.org/10.1016/j.ijbiomac.2021.05.044

Rojek B, Bartyzel A. DSC, TGA-FTIR and FTIR assisted by chemometric factor analysis and PXRD in assessing the incompatibility of the antiviral drug arbidol hydrochloride with pharmaceutical excipients. Molecules, 29(1), 264 (2024) https://doi.org/10.3390/molecules29010264

Kusiak-Nejman E. Size-dependent effects of ZnO nanoparticles on the photocatalytic degradation of phenol in a water solution. Appl. Surf. Sci., 541, 148416 (2021) https://doi.org/10.1016/j.apsusc.2020.148416

Hassett KJ, Higgins J. Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J. Control. Release, 335, 237–46 (2021) https://doi.org/10.1016/j.jconrel.2021.05.021

Ochapski DJ, Carvalho dos Santos C. Zeta potential and colloidal stability predictions for inorganic nanoparticle dispersions: effects of experimental conditions and electrokinetic models on the interpretation of results. Langmuir, 37(45), 13379–89 (2021) https://doi.org/10.1021/acs.langmuir.1c02056

Guo Y, Baldelli A. Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques. Sci. Rep., 12(1), 9949 (2022) https://doi.org/10.1038/s41598-022-13092-6

Hazra A, Sanyal D, De A, Chatterjee S. Development and in vitro characterization of capecitabine loaded biopolymeric vehicle for the treatment of colon cancer. J. Appl. Polym. Sci., 139(26), e52374 (2022) https://doi.org/10.1002/app.52374

Guo X, Li X, Chan L. Edible CaCO3 nanoparticles stabilized Pickering emulsion as calcium fortified formulation. J. Nanobiotechnology, 19(1), 67 (2021) https://doi.org/10.1186/s12951-021-00807-6

Luiz MT, Abriata JP. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. Eur. J. Pharm. Biopharm., 165, 127–48 (2021) https://doi.org/10.1016/j.ejpb.2021.05.011

Liaqat N, Jahan N. Green synthesized silver nanoparticles: optimization, characterization, antimicrobial activity, and cytotoxicity study by hemolysis assay. Front. Chem., 10, 952006 (2022) https://doi.org/10.3389/fchem.2022.952006

Madihah MA, Tang SG. Optimization of reaction parameters for the biosynthesis of selenium nanoparticles mediated by Backhousia citriodora aqueous extract. Appl. Ecol. Environ. Res., 23(1), 1203–21 (2025) https://doi.org/10.15666/aeer/2301_12031221

Alinejad Z, Raeesi M. Enhanced cysteine sensor based on modified gold nanoparticles with synergistic role of pH-responsive poly(N,N-dimethylaminoethyl methacrylate). Eur. Polym. J., 211, 113031 (2024) https://doi.org/10.1016/j.eurpolymj.2024.113031

Fosca M, Rau JV. Factors influencing the drug release from calcium phosphate cements. Bioact. Mater., 7, 341–63 (2022) https://doi.org/10.1016/j.bioactmat.2021.05.032

Rane BR, Jain AS, Mane NP, Patil V, Patil MS, Bavaskar KR. Fabrication and Evaluation of Carbocisteine-Loaded Solid Lipid Nanoparticles To Treat Pulmonary Infections. Journal of Applied Pharmaceutical Research, 12, 122–36 (2024) https://doi.org/10.69857/joapr.v12i6.661.

Zhang C, Ma C. CoFe2O4 nanoparticles modified amidation of N-doped carbon nanofibers hybrid catalysts to accelerate electrochemical kinetics of Li–S batteries with high sulfur loading. Chem. Eng. J., 481, 148374 (2024) https://doi.org/10.1016/j.cej.2023.148374

Ni J, Liu D, Wang W. Hierarchical defect-rich flower-like BiOBr/Ag nanoparticles/ultrathin g-C3N4 plasmonic Z-scheme heterojunction photocatalyst for accelerated visible-light-driven photothermal-photocatalytic oxytetracycline degradation. Chem. Eng. J., 419, 129969 (2021) https://doi.org/10.1016/j.cej.2021.129969